Baylor Scott & White Medical Center – Waxahachie was awarded the Magnet with Distinction® for nursing excellence from the American Nurses Credentialing Center (ANCC), the world's largest and most prominent nurse credentialing organization.
A breast cancer research study now open at Baylor University Medical Center in Dallas is believed to be the first of its kind to explore the ability of new weight loss GIP/GLP-1 receptor agonists to combat breast cancer recurrence in overweight or obese pa
...
Several Baylor Scott & White clinicians were recently named to Clarivate’s 2024 list of “Highly Cited Researchers” for authoring some of the most widely cited scientific publications in their fields, ranking among the top 1% of their peers.
The US Army Medical Research and Development Command, a division of the Department of Defense, awarded a $2.7 million grant to Dr. Ann Marie Warren, PhD, ABPP, principal investigator for Baylor Scott & White Research Institute, to research prevent Post-tra
...
In collaboration with Exact Sciences, Baylor Scott & White Research Institute are now enrolling its first patients in the Texas Multi-Cancer Early Detection (MCED) Registry.
Baylor University Medical Center’s uterus transplant program—the largest of its kind in the world—published the results of an eight-year trial in JAMA, finding the procedure is safe and effective, resulting in a high rate of live births. The seminal study
...
Baylor Scott & White The Heart Hospital – Plano1 has earned The Joint Commission's Gold Seal of Approval® and the American Heart Association's Heart-Check mark for Comprehensive Cardiac Center Certification, becoming the first hospital in Collin County and
...
The study results show exciting immune responses in patients with operable esophageal or gastroesophageal cancers given neoadjuvant immunotherapy and highlight the potential for monitoring circulating tumor DNA as a predictor for future intervention.
After more than 18 months of working to meet the criteria to become an authorized treatment center,
Baylor University Medical Center is poised to be one of the first in the nation to offer a newly FDA-approved tumor-infiltrating lymphocytes (TIL) cellula
...
